Drug Type Therapeutic vaccine |
Synonyms MaxiVax vaccine, MVX ONCO 1, MVX-ONCO-1 |
Target |
Mechanism CSF-2R stimulants(Granulocyte-macrophage colony-stimulating factor receptor stimulants), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Squamous Cell Carcinoma of Head and Neck | Phase 2 | CH | 25 Jul 2018 | |
Chordoma | Phase 2 | - | - |
NCT02999646 (ESMO2023) Manual | Phase 2 | Squamous Cell Carcinoma of Head and Neck Second line | 16 | luflltqygm(xjdqmxvtzl) = prgqbitniy pmmblcktwj (xdcvyyxbov ) View more | Positive | 21 Oct 2023 |